Not possible to specify

441 trials 102 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

Exploratory Bioavailability of Three Formulations of Gliclazide MR Tablets 120 mg (I.R.I.S.) in Healthy Volunteers Under Fed Conditions (Hig… Ended

2024-514298-23-00 No medical condicion. 3 2024-09-02
A study in healthy men to test how BI 1569912 is processed in the body Ended

2023-510464-12-00 Healthy volunteer trial 3 2024-08-26
A study in healthy men to test whether zongertinib influences the amount of 4 other medicines (dabigatran, rosuvastatin, metformin, and furo… Ended

2024-510628-38-00 Pharmacokinetic trial 3 2024-08-19
Bioequivalence of Amoxicillin and Clavulanic Acid 250 mg/62.5 mg/5 mL Powder for Oral Suspension versus Augmentin® Forte 250 mg/62.5 mg/5 mL… Ended

2024-513753-75-00 No medical condition. 2 2024-08-12
Bioequivalence of Nilotinib 200 mg Capsules in Healthy Participants Under Fasting Conditions. Ended

2024-514448-10-00 No medical condition. 2 2024-08-09
Bioequivalence of Amoxicillin and Clavulanic Acid 875 mg/125 mg Film-Coated Tablets in Healthy Participants Under Fed Conditions. Ended

2024-513752-15-00 No medical condition. 2 2024-08-01
A study to test how well healthy people tolerate spesolimab when given in 2 different ways. Ended

2023-510448-20-00 Healthy volunteer trial 3 2024-07-30
Bioequivalence of Amoxicillin and Clavulanic Acid 500 mg/125 mg Film-Coated Tablets in Healthy Participants Under Fed Conditions. Ended

2024-513751-32-00 No medical condition. 2 2024-07-24
A study in healthy men to test whether zongertinib influences the amount of 3 other medicines in the blood Ended

2023-510263-35-00 Pharmacokinetic trial 3 2024-07-22
Bioequivalence of Vortioxetine 5 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions. Ended

2023-509422-21-00 No medical condition. 2 2024-07-17
Bioequivalence of Betis®10 mg Film-Coated Tablets versus Clozan 10 mg tablets in Healthy Subjects Ended

2023-504901-34-00 No medical condition. 2 2024-07-15
A study to investigate the effect of oral ticagrelor on the pharmacokinetics of oral rosuvastatin when given in healthy participants Ended

2024-512197-99-00 Clinical trial healthy volunteer 3 2024-07-12
Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fasting Conditions. Ended

2024-512910-16-00 No medical condition. 2 2024-07-03
Phase 2a, double-blind, randomized, placebo-controlled trial of methylprednisolone versus placebo in patients with cognitive deficits in pos… Ended

2023-504826-21-00 Post COVID-19 Syndrome 4 2024-07-02
Bioequivalence clinical trial of two formulations of dapagliflozin. Ended

2023-506561-62-00 Healthy volunteers 2 2024-07-01
A study in healthy people to compare two different Sifrol® tablets Ended

2024-510764-23-00 Pharmacokinetic trial 2 2024-06-27
Bioequivalence of Tofacitinib 10 mg Film-Coated Tablets versus Xeljanz® 10 mg Film-Coated Tablets in Healthy Subjects Under Fasting Conditio… Ended

2024-512853-26-00 No medical condition 2 2024-06-27
A study in healthy men to test how well different doses of BI 3731579 are tolerated Ended

2023-510318-25-00 Healthy volunteer trial 1 2024-06-26
A Phase 1, Randomized, Open Label, Single-Dose Crossover Study to Assess the Relative Bioavailability, Food Effect, and Safety of Capsule Fo… Ended

2024-510915-31-00 Not applicable, healthy volunteers 3 2024-06-14
Bioequivalence clinical trial of two formulations of linagliptin Ended

2023-506562-31-00 Healthy volunteers 2 2024-06-14
Comparative Pharmacokinetic of S221237 Tablets in Healthy Participants Under Fed Conditions Ended

2024-511270-72-00 No medical condition 3 2024-06-13
Bioequivalence clinical trial of two formulations of edoxaban. Ended

2024-510795-20-00 Healthy volunteers 2 2024-06-11
A study in healthy people to compare how 2 different low dose formulations of BI 1015550 are taken up in the body Ended

2023-509951-15-00 Pharmacokinetic trial 2 2024-06-06
A study in healthy people to test how BI 1015550 is taken up in the body when given with or without food Ended

2023-509889-38-00 Healthy volunteer trial 3 2024-05-28